Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

177 Press Releases
DateTitleCompany
13 Apr 17 Ligand to Report First Quarter 2017 Results on May 9th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
05 Apr 17 Ligand Enters Commercial License and Supply Agreements with Marinus Pharmaceuticals for Captisol-Enabled Ganaxolone Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
28 Mar 17 Ligand Announces Licensing Partner Janssen Has Filed an IND for an Antibody Discovered Using the OmniAb® Technology Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
09 Mar 17 Ligand to Participate in Upcoming Investor Conference Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
28 Feb 17 Ligand Expands License with Sermonix to Include Worldwide Rights for Oral Lasofoxifene Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
27 Feb 17 Enrollment Completed in Ligand’s Phase 2 Trial of LGD-6972 in Type 2 Diabetes Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
14 Feb 17 Dr. Christel Iffland Joins Ligand as Vice President, Antibody Technologies, Expands Team Focused on OmniAb Drug Discovery Platform Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
13 Feb 17 Reminder: Ligand to Host Analyst Day on February 28th in New York City Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
24 Jan 17 Ligand to Host Analyst Day on February 28th in New York City Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
23 Jan 17 Ligand to Report Fourth Quarter and Full Year 2016 Results on February 23rd Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
22 Dec 16 Ligand Enters Commercial License and Supply Agreements for Captisol®-enabled trametinib Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
22 Dec 16 Ligand Enters into Worldwide OmniAb® Platform License Agreement with ONO PHARMACEUTICAL CO., LTD. Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
21 Nov 16 Ligand Partner Retrophin Reports Additional Positive Data from Phase 2 DUET Study of Sparsentan in Focal Segmental Glomerulosclerosis at ASN Kidney Week 2016 Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
24 Oct 16 Ligand Partner Melinta Therapeutics Submits Baxdela New Drug Application for Hospital-Treated Skin Infections Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
13 Oct 16 Ligand Announces Third Quarter 2016 Earnings Release Date and Participation in the Stephens Fall Investment Conference Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
22 Sep 16 Ligand Licenses Four Programs to Seelos Therapeutics Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
16 Sep 16 Ligand Enters OmniAb® License Agreement with TeneoBio, Inc. Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
13 Sep 16 Ligand Initiates Phase 2 Trial with LGD-6972 in Type 2 Diabetes Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
28 Mar 16 Ligand Enters Into OmniAb® Platform License Agreement With ABBA Therapeutics Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
18 Nov 15 Ligand Provides Highlights from Today’s Analyst Day Event Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
22 Apr 16 Ligand Announces First Quarter 2016 Earnings Reporting Date and Participation in Four Upcoming Investor Conferences Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
15 Mar 16 Ligand Partner Spectrum Pharmaceuticals Receives FDA Approval of EVOMELA™ (melphalan) for Injection Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
04 May 16 Ligand Acquires Portfolio of Synthetic Royalty and Milestone Rights from CorMatrix® Cardiovascular for $17.5 Million Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
08 Dec 15 RODES Signs Exclusive Captisol® Licensing Agreement with Ligand Pharmaceuticals for Three Programs Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
13 Jan 16 Ligand Enters Into OmniAb® Platform License Agreement with Emergent BioSolutions Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
22 Jan 16 Ligand to Report Fourth Quarter and Full Year 2015 Results on February 10th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
29 Jul 16 Ligand Announces Multi-Program LTP Technology Licensing Agreement with Nucorion Pharmaceuticals Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
30 Jun 16 Ligand Receives $4 Million from Expansion of Two OmniAb® License Agreements Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
08 Jul 16 Ligand Enters into OmniAb® Platform License Agreement with Gilead Sciences Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
02 Feb 16 Ligand Enters Into OmniAb® Platform License Agreement with Tizona Therapeutics Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.